申请人:Actelion Pharmaceuticals Ltd.
公开号:US08236801B2
公开(公告)日:2012-08-07
The invention relates to novel 2-aza-bicyclo[2.2.1]heptane derivatives of formula (I),
wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
本发明涉及新颖的2-aza-bicyclo[2.2.1]庚烷衍生物(I)的公式,其中A、B、n和R1如说明书所述,并且涉及将这种化合物或这种化合物的药学上可接受的盐用作药物,特别是用作促醒素受体拮抗剂。